Cancer Biopsy Market Revenue was valued at USD 4.5 Billion in 2024 and is estimated to reach USD 10.2 Billion by 2033, growing at a CAGR of 9.8% from 2026 to 2033.
The South Korea Cancer Biopsy Market is experiencing significant growth, driven by the increasing demand for early cancer diagnosis and advancements in biopsy techniques. The market includes various biopsy types, such as needle biopsies, surgical biopsies, and liquid biopsies, each serving different diagnostic needs. These biopsy methods are essential for providing accurate cancer detection, which is crucial for determining the most effective treatment plans for patients.
In South Korea, the demand for cancer biopsies is rising due to the country’s aging population and the growing prevalence of various cancer types, including lung, breast, and stomach cancers. The country is known for its strong healthcare infrastructure and high-quality medical facilities, which contribute to the rapid adoption of new diagnostic technologies. Additionally, the government’s emphasis on healthcare innovation and patient care has led to increased investments in cancer diagnosis and treatment solutions, further boosting the biopsy market.
Industries driving the demand for cancer biopsy services in South Korea include hospitals, diagnostic laboratories, and research institutions. Hospitals are the primary users of cancer biopsy services, as they require advanced diagnostic tools to confirm cancer diagnoses and monitor treatment progress. Diagnostic laboratories are also key players in the market, offering specialized services to assist healthcare providers with accurate and timely cancer detection. Furthermore, research institutions focus on the development of innovative biopsy technologies and new cancer biomarkers, contributing to market growth.
Liquid biopsies, in particular, are gaining traction in South Korea due to their non-invasive nature and ability to detect cancer at earlier stages. This type of biopsy involves analyzing blood samples to identify cancer-related genetic mutations, offering a less invasive alternative to traditional needle biopsies. As technology continues to evolve, the demand for liquid biopsies is expected to increase, driving further growth in the Cancer Biopsy Market.
In summary, the South Korea Cancer Biopsy Market is expanding rapidly, fueled by the country’s advanced healthcare system, growing cancer prevalence, and increasing demand for innovative biopsy methods. With continuous advancements in biopsy technologies, the market is expected to play a pivotal role in the early detection and treatment of cancer.
Get an In-Depth Research Analysis of the South Korea Cancer Biopsy Market Size And Forecast [2025-2032]
Qiagen N.V.
Illumina
Inc
ANGLE Plc
Myriad Genetics
Hologic
Inc
Biocept
Inc
Thermo Fisher Scientific
Inc
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL
Inc
Guardant Health
Exact Sciences Corporation
Freenome Holdings
Inc
Oncimmune
Chronix Biomedical
Inc
Personal Genome Diagnostics Inc
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the South Korea Cancer Biopsy Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the South Korea Cancer Biopsy Market
Needle Biopsy
Excisional Biopsy
Incisional Biopsy
Endoscopic Biopsy
Fine-Needle Aspiration Biopsy (FNAB)
Imaging-guided Biopsy
Optical Biopsy
Molecular Biopsy
Liquid Biopsy
Electromagnetic Navigation Biopsy
Breast Cancer
Lung Cancer
Colorectal Cancer
Prostate Cancer
Gynecological Cancer
Hospitals
Diagnostic Laboratories
Research Institutions
Specialty Clinics
Ambulatory Surgical Centers
Tissue Samples
Blood Samples
Saliva Samples
Urinary Samples
Bone Marrow Samples
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
For More Information or Query, Visit @ South Korea Cancer Biopsy Market Research Analysis
1. Introduction of the South Korea Cancer Biopsy Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. South Korea Cancer Biopsy Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. South Korea Cancer Biopsy Market, By Type
6. South Korea Cancer Biopsy Market, By Application
7. South Korea Cancer Biopsy Market, By Geography
Asia-Pacific
China
Japan
Korea
India
Australia
Indonesia
Thailand
Philippines
Malaysia and Vietnam
8. South Korea Cancer Biopsy Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Research and Consulting firm servicing over 5000+ clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/